Literature DB >> 7625655

Live attenuated vaccinia and other poxviruses as delivery systems: public health issues.

M E Perkus1, J Taylor, J Tartaglia, S Pincus, E B Kauffman, J A Tine, E Paoletti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7625655     DOI： 10.1111/j.1749-6632.1995.tb44454.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Preferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-β.

Authors:  Yuan Zhao; Yan Fei Adams; Michael Croft
Journal:  Viral Immunol       Date:  2011-09-29       Impact factor: 2.257

Review 2.  Vaccinia virus vaccines: past, present and future.

Authors:  Bertram L Jacobs; Jeffrey O Langland; Karen V Kibler; Karen L Denzler; Stacy D White; Susan A Holechek; Shukmei Wong; Trung Huynh; Carole R Baskin
Journal:  Antiviral Res       Date:  2009-06-26       Impact factor: 5.970

Review 3.  OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses.

Authors:  John Goulding; Vikas Tahiliani; Shahram Salek-Ardakani
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 4.  Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.

Authors:  Sandeep S Patil; Ivaylo Gentschev; Ingo Nolte; Gregory Ogilvie; Aladar A Szalay
Journal:  J Transl Med       Date:  2012-01-04       Impact factor: 5.531

Review 5.  Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications.

Authors:  Minoru Kidokoro; Hisatoshi Shida
Journal:  Vaccines (Basel)       Date:  2014-10-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.